---
figid: PMC12122774__or-19-1549416-g003
figtitle: 'Key Molecular Pathways in Endometrial Carcinoma: ARID1A, PTEN, and Wnt
  Signaling Mutations, and PI3K Activation lead to Tumorigenesis'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12122774
filename: or-19-1549416-g003.jpg
figlink: /pmc/articles/PMC12122774/figure/F3/
number: F3
caption: 'Key Molecular Pathways in Endometrial Carcinoma: ARID1A, PTEN, and Wnt Signaling
  Mutations, and PI3K Activation lead to Tumorigenesis. Receptor Tyrosine Kinases
  (RTK) – Growth factors, such as VEGFR/PDGFR, activate RTKs, triggering the PI3K
  pathway. PI3K Activation–This leads to the conversion of PIP2 to PIP3, which PTEN
  normally regulates. However, PTEN inactivation disrupts this control, contributing
  to tumorigenesis. ARID1A Mutation–Mutations in ARID1A disrupt the function of the
  BAF250a complex, a critical player in chromatin remodeling, further contributing
  to gene dysregulation and cancer progression. Wnt Pathway Mutation–Mutations in
  the Wnt signaling pathway also play a role by activating downstream targets that
  promote cell proliferation and inhibit normal gene regulatory mechanisms'
papertitle: 'A brief review of Lynch syndrome: understanding the dual cancer risk
  between endometrial and colorectal cancer'
reftext: Sneha Pallatt, et al. Oncol Rev. 2025;19(NA).
year: '2025'
doi: 10.3389/or.2025.1549416
journal_title: Oncology Reviews
journal_nlm_ta: Oncol Rev
publisher_name: Frontiers Media SA
keywords: endometrial cancer | colorectal cancer | Lynch syndrome | genetic mutations
  | risk factors
automl_pathway: 0.9453474
figid_alias: PMC12122774__F3
figtype: Figure
redirect_from: /figures/PMC12122774__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12122774__or-19-1549416-g003.html
  '@type': Dataset
  description: 'Key Molecular Pathways in Endometrial Carcinoma: ARID1A, PTEN, and
    Wnt Signaling Mutations, and PI3K Activation lead to Tumorigenesis. Receptor Tyrosine
    Kinases (RTK) – Growth factors, such as VEGFR/PDGFR, activate RTKs, triggering
    the PI3K pathway. PI3K Activation–This leads to the conversion of PIP2 to PIP3,
    which PTEN normally regulates. However, PTEN inactivation disrupts this control,
    contributing to tumorigenesis. ARID1A Mutation–Mutations in ARID1A disrupt the
    function of the BAF250a complex, a critical player in chromatin remodeling, further
    contributing to gene dysregulation and cancer progression. Wnt Pathway Mutation–Mutations
    in the Wnt signaling pathway also play a role by activating downstream targets
    that promote cell proliferation and inhibit normal gene regulatory mechanisms'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PDGFRB
  - PDGFRA
  - NFIA
  - NFIB
  - NFIC
  - NFIX
  - ESCO1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PTEN
  - ARID1A
  - carcinoma
  - Endometrial carcinoma
---
